CY1120192T1 - Ενωσεις για την ενισχυση της γνωστικης λειτουργιας - Google Patents

Ενωσεις για την ενισχυση της γνωστικης λειτουργιας

Info

Publication number
CY1120192T1
CY1120192T1 CY20181100454T CY181100454T CY1120192T1 CY 1120192 T1 CY1120192 T1 CY 1120192T1 CY 20181100454 T CY20181100454 T CY 20181100454T CY 181100454 T CY181100454 T CY 181100454T CY 1120192 T1 CY1120192 T1 CY 1120192T1
Authority
CY
Cyprus
Prior art keywords
unions
functioning
enhance knowledge
enhance
knowledge
Prior art date
Application number
CY20181100454T
Other languages
English (en)
Inventor
Florian MONTEL
Eric JNOFF
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of CY1120192T1 publication Critical patent/CY1120192T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αφορά παράγωγα 2-οξο-1-πυρρολιδινυλο-τριαζολίου, διαδικασίες για την παρασκευή τους, φαρμακευτικές συνθέσεις που τα περιέχουν και τη χρήση τους ως φαρμακευτικά προϊόντα για την ενίσχυση της γνωστικής λειτουργίας ή για την καταπολέμηση της γνωστικής έκπτωσης.
CY20181100454T 2013-08-02 2018-05-03 Ενωσεις για την ενισχυση της γνωστικης λειτουργιας CY1120192T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13179148 2013-08-02
PCT/EP2014/066159 WO2015014785A1 (en) 2013-08-02 2014-07-28 Compounds for enhancing the cognitive function
EP14748150.1A EP3027606B1 (en) 2013-08-02 2014-07-28 Compounds for enhancing the cognitive function

Publications (1)

Publication Number Publication Date
CY1120192T1 true CY1120192T1 (el) 2018-12-12

Family

ID=48914141

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100454T CY1120192T1 (el) 2013-08-02 2018-05-03 Ενωσεις για την ενισχυση της γνωστικης λειτουργιας

Country Status (14)

Country Link
US (1) US9630948B2 (el)
EP (1) EP3027606B1 (el)
CY (1) CY1120192T1 (el)
DK (1) DK3027606T3 (el)
ES (1) ES2666134T3 (el)
HR (1) HRP20180832T1 (el)
HU (1) HUE037644T2 (el)
LT (1) LT3027606T (el)
NO (1) NO3027606T3 (el)
PL (1) PL3027606T3 (el)
PT (1) PT3027606T (el)
RS (1) RS57410B1 (el)
SI (1) SI3027606T1 (el)
WO (1) WO2015014785A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022090533A1 (en) 2020-11-02 2022-05-05 Syndesi Therapeutics Sa Cocrystal
JP2024508052A (ja) 2021-02-26 2024-02-21 シンデシ セラピューティクス ソシエテ アノニム 認知障害の治療のための化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542322A (ja) * 2005-06-01 2008-11-27 ユセベ ファルマ ソシエテ アノニム ２−オキソ−１−ピロリジン誘導体
EP2461808A2 (en) 2009-08-07 2012-06-13 UCB Pharma S.A. Methods for enhancing the cognitive function

Also Published As

Publication number Publication date
SI3027606T1 (en) 2018-06-29
US9630948B2 (en) 2017-04-25
NO3027606T3 (el) 2018-07-28
EP3027606A1 (en) 2016-06-08
PL3027606T3 (pl) 2018-07-31
LT3027606T (lt) 2018-04-25
HUE037644T2 (hu) 2018-09-28
RS57410B1 (sr) 2018-09-28
PT3027606T (pt) 2018-04-17
US20160185761A1 (en) 2016-06-30
DK3027606T3 (en) 2018-04-30
EP3027606B1 (en) 2018-02-28
ES2666134T3 (es) 2018-05-03
WO2015014785A1 (en) 2015-02-05
HRP20180832T1 (hr) 2018-06-29

Similar Documents

Publication Publication Date Title
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
PH12016501898B1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
WO2015081257A3 (en) Aminopyridine derivatives as tam family kinase inhibitors
CL2018000565A1 (es) Compuestos derivados de piridinona dicarboxamida, inhibidores de bromodominio; composicion farmaceutica; combinacion farmaceutica; utiles en el tratamiento de enfermedades autoinmunitarias, inflamatorias, virales y cancer, entre otras.
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
IL272638A (en) History of quinoxaline, their preparation and pharmaceutical preparations containing them
IL256610B (en) Pyrimidine history, their preparation and pharmaceutical preparations containing them
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
MX367669B (es) Compuestos antiproliferativos y sus composiciones farmacéuticas y usos.
HK1256674A1 (zh) 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途
EA201791600A1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
EP3124486A4 (en) Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications of antitumor thereof
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
CY1121105T1 (el) Φαρμακοτεχνικη μορφη αταζαναβιρης και κομπισιστατης για θεραπεια hiv
TR201901977T4 (tr) Cxcr3 reseptörü modülatörleri olarak (r)-2-metil-piperazin türevleri.
PH12018501709A1 (en) Naphthridinedione derivatives
TR201901228T4 (tr) Vortioksetin piroglutamat.
IL272806B1 (en) The history of boronic acid, its preparation and pharmaceutical preparations containing it
EP3483166A4 (en) IMIDAZOOXAZOLE DERIVATIVE WITH ANTITUMORIC EFFECT AND PHARMACEUTICAL COMPOSITION THEREWITH
EA201491517A1 (ru) N-этил-n-фенил-1,2-дигидро-4,5-дигидрокси-1-метил-2-оксо-3-хинолинкарбоксамид, его получение и применения